N,N-二丙基色胺盐酸盐 | 7558-73-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: N,N-二丙基色胺盐酸盐
• 英文名称: dipropyltryptamine hydrochloride
• 英文别名: N,N-Dipropyltryptamine hydrochloride；N-[2-(1H-indol-3-yl)ethyl]-N-propylpropan-1-amine;hydrochloride
• CAS: 7558-73-8
• 化学式: C₁₆H₂₄N₂*(x)ClH
• 分子量: 280.83
• InChiKey: AIAASKTUEVUIQM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.58
• 重原子数：
  19
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  20.2
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  sodium cyclamate 、 N,N-二丙基色胺盐酸盐 以 水 为溶剂， 以58 %的产率得到dipropyltryptamine cyclamate
  参考文献：
  名称：

  [EN] TRANSMUCOSAL DELIVERY OF PSYCHOACTIVE COMPOUNDS
  [FR] ADMINISTRATION TRANSMUCOSALE DE COMPOSÉS PSYCHOACTIFS

  摘要：

  The present disclosure relates to psychoactive, such as psychedelic compounds, pharmaceutical formulations and dosage units for the transmucosal delivery of psychoactive compounds, comprising a sweetener salt or sweetener ionic liquid of a psychoactive compound. The compounds, formulations and dosage units according to the invention are advantageously employed in a method for the nasal, buccal, sublabial, or sublingual administration of a psychoactive, such as a psychedelic compound to a subject. Also disclosed are compounds, formulations and compositions for use as a medicament in a method of prophylactically or curatively treating a subject suffering from a psychiatric disease or disorder.

  公开号：

  WO2023177294A1

文献信息

• [EN] TRANSMUCOSAL DELIVERY OF PSYCHOACTIVE COMPOUNDS<br/>[FR] ADMINISTRATION TRANSMUCOSALE DE COMPOSÉS PSYCHOACTIFS
  申请人：[en]PLETHORA THERAPEUTICS B.V.

  公开号：WO2023177294A1

  公开（公告）日：2023-09-21

  The present disclosure relates to psychoactive, such as psychedelic compounds, pharmaceutical formulations and dosage units for the transmucosal delivery of psychoactive compounds, comprising a sweetener salt or sweetener ionic liquid of a psychoactive compound. The compounds, formulations and dosage units according to the invention are advantageously employed in a method for the nasal, buccal, sublabial, or sublingual administration of a psychoactive, such as a psychedelic compound to a subject. Also disclosed are compounds, formulations and compositions for use as a medicament in a method of prophylactically or curatively treating a subject suffering from a psychiatric disease or disorder.